Barbara Kuźnar-Kamińska

8PUBLICATIONS
24CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)Predictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 12, 2026
Nucleotide Variant in the SLC26A9 Gene in Two Siblings with Cystic Fibrosis.

|Apr 16, 2025
Low serum neopterin early indicates durable benefits of atezolizumab and pembrolizumab therapy in advanced lung cancer.

Anna Siemiątkowska, Barbara Kuźnar-Kamińska, Maciej Bryl

|Jan 11, 2025
A Novel Liquid Chromatography-Tandem Mass Spectrometry Method to Quantify Tryptophan and Its Major Metabolites in Serum to Support Biomarker Studies in Patients with Cancer Undergoing Immunotherapy.

Anna Siemiątkowska, Barbara Kuźnar-Kamińska, Katarzyna Kosicka-Noworzyń

|Jan 08, 2025
Circulating microRNAs as a Prognostic Tool to Determine Treatment Efficacy in Lung Cancer Patients Undergoing Pembrolizumab PD-1 Blockade Immunotherapy.

Mishfak A Mohamed Mansoor, Xiang Zhu, Sarah Aslam Ashiqueali

|Jun 27, 2024
Association of Obesity and Severe Asthma in Adults.

Aneta Elżbieta Olejnik, Barbara Kuźnar-Kamińska

|Feb 24, 2024
Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients.

Natalia Galant, Marcin Nicoś, Barbara Kuźnar-Kamińska

Pageof 2

Frequent Collaborators

2 joint publications

Franciszek K Główka

2 joint publications

Katarzyna Kosicka-Noworzyń

2 joint publications

Anna Siemiątkowska

1 joint publications

Adam Krusiński